Search
for
Sort by
Research 361–390 of 372
- Case report: Acrodermatitis enteropathica result from a novel SLC39A4 gene mutation
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Sesame and Pumpkin Seed Oil are New Effective Topical Therapies for Alopecia Areata
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- 26-Year-Old Man With New Abdominal Pain
- Pancreatic cancer
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- TONGUE, RED
- Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α.
- DIETHYLPROPION
- [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].
- Table 1_Contact sensitization to hair care allergens in scalp seborrheic dermatitis: associations with disease severity and microbiota profiles.docx
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Potential of Natural Products in Hangeshashinto Water Extract on the Direct Suppression of Stomatitis Induced by Intra-/Extracellular Advanced Glycation End-Products
- Fever, Maculopapular Rash and Severe Aphthous Stomatitis in a Renal Transplant Patient
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Mucocutaneous reactions to chemotherapy
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous complications of chemotherapeutic agents
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- Mucocutaneous side effects of antineoplastic chemotherapy
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- THALLIUM POISONING
- Colchicine in Managing Skin Conditions: A Systematic Review
- [Cutaneous manifestations of zinc deficiency in ethylic cirrhosis].
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Pay-For-Delay Settlements in theWake of Actavis
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique